Other and unspecified immunodeficiencies with predominantly antibody defects

D3_IMMUDEFANTIBODYNAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D80.8, D80.9 Hospital discharge: ICD-9 — 2790C\|2790X Cause of death: ICD-10 — D80.8, D80.9 Cause of death: ICD-9 — 2790C\|2790X 2 out of 7 registries used, show all original rules.	441
4. Check minimum number of events None	441
5. Include endpoints None	441
6. Filter based on genotype QC (FinnGen only)	441

Control definitions (FinnGen only)

Control exclude: D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	D3_IMMUDEFANTIBODYNAS
CONTROL_EXCLUDE	D3_IMMUNEMECHANISM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D80[8-9]
HD_ICD_9	2790C\|2790X
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D80[8-9]
COD_ICD_9	2790C\|2790X
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified immunodeficiencies with predominantly antibody defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1635	939	695
Only index persons	1497	874	623
Unadjusted period prevalence (%)
Whole population	0.02	0.03	0.02
Only index persons	0.03	0.03	0.02
Median age at first event (years)
Whole population	44.50	48.34	39.35
Only index persons	44.51	48.28	39.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	441	292	149
Unadjusted period prevalence (%)	0.09	0.10	0.07
Median age at first event (years)	49.39	49.73	48.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
404: Matched controls
4041

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

+∞

302.5

251

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

+∞

215.5

187

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

+∞

151.9

136

120

Kela drug reimbursment

Hypogammaglobulinaemia

+∞

149.5

134

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

+∞

142.3

128

ZX120

NOMESCO Finland

Intravenous

17.1

109.1

192

203

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

29.3

99.8

138

WW200

NOMESCO Finland

Immunization

36.5

89.7

116

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

+∞

87.8

6BA02

NOMESCO Finland

357.3

87.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

23.0

79.4

118

GD1AA

NOMESCO Finland

Thorax X-ray examination

7.7

76.0

300

1104

H02AB06

ATC

prednisolone; systemic

7.5

71.1

316

1310

J01MA14

ATC

moxifloxacin; systemic

11.5

67.1

137

172

J01MA12

ATC

levofloxacin; systemic

7.8

65.9

183

386

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

+∞

65.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

7.5

65.1

189

424

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

31.8

64.6

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

12.1

63.6

125

144

TDM10

NOMESCO Finland

Puncture of maxillary antrum

23.1

60.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

20.4

58.2

TPH04

NOMESCO Finland

Cathetrisation of vein

6.4

57.7

193

506

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.3

53.3

148

296

Z3231

NOMESCO Finland

Registered nurse

5.4

52.8

224

759

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

11.6

50.8

100

111

C01CA24

ATC

epinephrine; parenteral

10.0

48.9

105

137

H02AB07

ATC

prednisone; oral

6.7

48.3

143

306

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.0

46.7

201

666

R03DC03

ATC

montelukast; oral

5.7

45.8

158

406

J45.0

ICD-10 Finland

Predominantly allergic asthma

7.9

45.7

115

193

Z2221

NOMESCO Finland

Medical doctor

4.7

44.5

212

770

J45.9

ICD-10 Finland

Asthma, unspecified

5.5

43.6

156

414

J47

ICD-10 Finland

Bronchiectasis

28.6

43.4

J45.1

ICD-10 Finland

Nonallergic asthma

8.5

42.4

100

150

R50.9

ICD-10 Finland

Fever, unspecified

5.5

41.6

146

376

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

13.9

41.3

J01FA06

ATC

roxithromycin; oral

4.3

41.2

252

1132

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.3

39.7

204

771

ZXE10

NOMESCO Finland

More than one and less than three hours

4.2

39.6

230

973

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

5.1

39.5

149

412

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

4.9

39.0

155

453

TGC00

NOMESCO Finland

Bronchial lavation

23.0

38.7

R03BA02

ATC

budesonide; inhalant

4.9

37.5

149

432

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

9.9

37.4

Z3226

NOMESCO Finland

Physiotherapist

4.6

37.1

159

497

R03BB04

ATC

tiotropium bromide; inhalant

7.4

36.8

161

R4110

NOMESCO Finland

Physiotherapy

4.2

36.7

188

693

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

8.4

36.7

126

UGC12

NOMESCO Finland

Flexible bronchoscopy

9.9

36.5

J01.0

ICD-10 Finland

Acute maxillary sinusitis

4.2

34.8

171

600

XW000

NOMESCO Finland

Bone marrow biopsy

13.4

34.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.6

34.1

R03AK06

ATC

salmeterol and fluticasone; inhalant

5.1

32.8

117

296

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

+∞

32.7

ZXE00

NOMESCO Finland

One hour or less

3.5

32.1

240

1179

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.3

31.9

184

R03AC02

ATC

salbutamol; inhalant

3.7

31.8

289

1645

H02AB09

ATC

hydrocortisone; systemic

14.3

31.4

R03DA04

ATC

theophylline; systemic, rectal

11.3

30.1

JN4BD

NOMESCO Finland

Extensive body CT

5.8

29.7

195

R03AC12

ATC

salmeterol; inhalant

10.1

29.7

J46

ICD-10 Finland

Status asthmaticus

13.7

29.7

ZX108

NOMESCO Finland

Inhalation

61.6

29.6

J01FA10

ATC

azithromycin; systemic

3.7

29.5

314

1963

J05AB11

ATC

valaciclovir; oral

5.0

29.3

106

269

H02AB04

ATC

methylprednisolone; systemic

4.6

29.0

115

320

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

52.8

28.9

ZXD10

NOMESCO Finland

Scheduled procedure

3.3

28.7

219

1057

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

+∞

28.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

3.4

28.4

282

1645

Z2446

NOMESCO Finland

Social worker

6.2

28.2

160

WX408

NOMESCO Finland

General anesthesy, balanced

3.5

28.1

180

756

R03BB01

ATC

ipratropium bromide; inhalant

12.8

27.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

9.1

27.6

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

66.9

27.4

WW500

NOMESCO Finland

Blood transfusion

10.3

27.2

R03AC13

ATC

formoterol; inhalant

8.8

27.2

A03FA01

ATC

metoclopramide; systemic, rectal

3.9

27.1

138

478

R01AD09

ATC

mometasone; nasal

3.2

26.7

254

1410

XF400

NOMESCO Finland

ECG with 12 standard connections

4.2

26.6

118

363

D80.2

ICD-10 Finland

Selective deficiency of immunoglobulin A [IgA]

+∞

26.3

J02AC01

ATC

fluconazole; systemic

3.1

25.9

229

1197

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

3.1

25.6

256

1451

R01AD08

ATC

fluticasone; nasal

3.2

25.5

181

810

J01MA02

ATC

ciprofloxacin; systemic

3.1

25.1

201

975

R05

ICD-10 Finland

Cough

3.7

25.0

129

449

UDH02

NOMESCO Finland

Rhinopharyngoscopy

5.8

24.7

153

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

6.2

24.7

131

R01AD05

ATC

budesonide; nasal

5.7

24.5

155

J32.4

ICD-10 Finland

Chronic pansinusitis

20.6

24.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.3

24.2

176

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

9.1

23.7

J01FA09

ATC

clarithromycin; systemic

3.0

23.6

189

905

J01FF01

ATC

clindamycin; systemic

3.2

23.4

161

692

ZXA10

NOMESCO Finland

Bilateral

3.6

23.2

126

453

Z01.8

ICD-10 Finland

Other specified special examinations

3.4

23.1

137

526

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

+∞

23.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.8

22.9

101

R03AK07

ATC

formoterol and budesonide; inhalant

3.4

22.7

133

507

D84.18

ICD-10 Finland

Other specified defect in the complement system

+∞

22.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

16.5

21.9

L03AA02

ATC

filgrastim; parenteral

11.6

21.9

R06.0

ICD-10 Finland

Dyspnoea

3.3

21.7

135

535

ZX112

NOMESCO Finland

Subcutaneous

22.3

21.6

M05BA04

ATC

alendronic acid; oral

6.4

21.6

105

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

25.9

21.1

J05AB01

ATC

aciclovir; systemic

3.3

21.1

129

503

D70.82

ICD-10 Finland

Drug-induced neutropenia

16.0

21.1

J45.8

ICD-10 Finland

Mixed asthma

10.1

20.9

XQ800

NOMESCO Finland

Prick test

5.0

20.9

169

A02BC02

ATC

pantoprazole; systemic

2.8

20.8

289

1896

R03BA05

ATC

fluticasone; inhalant

3.3

20.8

127

495

J01DA06

ATC

[U] cefuroxime; systemic

3.6

20.4

103

346

J01AA02

ATC

doxycycline; systemic

3.3

20.3

341

2509

H04.10

ICD-10 Finland

Dry eye syndrome

4.8

20.2

175

A07AA02

ATC

nystatin; oral

5.5

20.1

128

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

6.8

20.0

N03AX16

ATC

pregabalin; oral

3.1

20.0

132

541

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

20.0

321

XA800

NOMESCO Finland

Neuropsychological investigation

6.9

19.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.9

19.9

163

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.7

19.8

194

1022

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

26.2

19.8

J01FA15

ATC

telithromycin; oral

4.2

19.5

229

R03AK11

ATC

formoterol and fluticasone; inhalant

10.4

19.3

R06AE07

ATC

cetirizine; oral

2.6

19.1

227

1326

J31.0

ICD-10 Finland

Chronic rhinitis

5.1

19.0

141

GD1AD

NOMESCO Finland

Thorax CT examination

8.8

19.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.6

18.9

322

2790C

ICD-9 Finland

Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]

+∞

18.9

N02AX02

ATC

tramadol; systemic, rectal

2.6

18.8

203

1121

R03BA01

ATC

beclometasone; inhalant

3.7

18.7

283

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.7

18.7

188

997

UJF30

NOMESCO Finland

Ileoscopy through colon

4.3

18.6

195

L04AX01

ATC

azathioprine; systemic

7.6

18.5

J01DB01

ATC

cefalexin; oral

3.5

18.2

359

2801

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

6.3

18.2

TAB00

NOMESCO Finland

Lumbar puncture

6.4

18.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.7

18.0

159

773

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.9

18.0

ZX114

NOMESCO Finland

Intramuscular

12.3

17.8

D80.6

ICD-10 Finland

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

+∞

17.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

14.0

17.7

UJF32

NOMESCO Finland

Coloscopy

2.9

17.7

131

572

1XC02

NOMESCO Finland

19.7

17.6

ZXE20

NOMESCO Finland

More than three and less than five hours

3.5

17.3

306

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

16.9

17.3

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

52.4

17.1

WZC30

NOMESCO Finland

Teaching

3.5

17.0

286

R03AK08

ATC

formoterol and beclometasone; inhalant

7.1

17.0

R01BA52

ATC

pseudoephedrine, combinations; oral

2.6

16.9

163

830

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.6

16.9

173

909

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

10.8

16.7

R03BA08

ATC

ciclesonide; inhalant

4.2

16.7

182

A01AB09

ATC

miconazole; local oral

4.3

16.6

172

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

176.9

16.6

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

6.1

16.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.6

16.4

269

R03DC01

ATC

zafirlukast; oral

13.6

16.4

N02AA05

ATC

oxycodone; systemic

3.7

16.3

247

E0000UV

ATC

2.5

16.3

198

1135

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.0

16.3

108

436

C03CA01

ATC

furosemide; systemic

2.9

16.1

115

486

N03AX12

ATC

gabapentin; oral

3.3

15.9

312

ZXA00

NOMESCO Finland

Right side

2.7

15.7

135

638

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

15.6

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

39.7

15.5

J01DA01

ATC

[U] cefalexin; systemic

2.4

15.4

277

1916

J20

ICD-10 Finland

Acute bronchitis

3.9

15.3

196

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

14.7

15.2

R03AC03

ATC

terbutaline; inhalant

3.2

15.2

322

Z3229

NOMESCO Finland

Other healthcare associate professional

4.3

15.1

156

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.6

15.1

131

TPX10

NOMESCO Finland

Implantation of vascular injection port

8.3

14.9

L04AA06

ATC

mycophenolic acid; systemic

13.9

14.9

S01GX01

ATC

cromoglicic acid; ophthalmic

2.7

14.8

125

580

A41.9

ICD-10 Finland

Sepsis, unspecified

7.4

14.7

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

14.7

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

37.5

14.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

14.4

121

558

N06AX21

ATC

duloxetine; oral

3.5

14.1

233

N05CF01

ATC

zopiclone; oral

2.4

14.1

147

764

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.2

14.0

146

R4120

NOMESCO Finland

Occupational therapy

5.0

14.0

102

Z2445

NOMESCO Finland

Psychologist

5.3

13.9

ZXD05

NOMESCO Finland

Urgent procedure

2.4

13.7

159

869

R1250

NOMESCO Finland

Evaluation of functional capability

10.6

13.7

A02BC01

ATC

omeprazole; systemic

2.5

13.6

132

659

A04AA01

ATC

ondansetron; systemic, rectal

4.5

13.5

120

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.3

13.5

130

R81

ICPC

Pneumonia

9.0

13.5

J45

ICD-10 Finland

Asthma

3.5

13.5

212

X59

ICD-10 Finland

Exposure to unspecified factor

2.8

13.5

101

433

ZXA05

NOMESCO Finland

Left side

2.5

13.1

123

600

RS221

NOMESCO Finland

13.6

13.1

ZX121

NOMESCO Finland

Central venous catheter

29.5

13.1

D64.9

ICD-10 Finland

Anaemia, unspecified

4.0

13.0

146

B29

ICPC

Lymph/immune mech sympt/complt other

51.7

12.9

WX002

NOMESCO Finland

Sedation and analgesia

2.7

12.6

100

443

M04AA01

ATC

allopurinol; systemic

3.6

12.6

188

N05BA01

ATC

diazepam; systemic, rectal

3.0

12.6

303

M36.8*D80.1

ICD-10 Finland

Systemic disorders of connective tissue in hypogammaglobulinaemia

+∞

12.6

D84.19

ICD-10 Finland

Unspecified defect in the complement system

+∞

12.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.8

12.5

156

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

5.4

12.3

127

Kela drug reimbursment

Transplant complication

12.9

12.3

ZXD20

NOMESCO Finland

Day surgery

2.9

12.2

322

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.7

12.2

165

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

9.1

12.2

ZY010

NOMESCO Finland

Hospital outpatient

4.4

12.1

113

R01AD12

ATC

fluticasone furoate; nasal

2.3

12.1

154

867

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.9

12.0

145

R06AX27

ATC

desloratadine; oral

2.3

12.0

149

831

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

11.0

11.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

11.8

169

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.3

11.8

146

810

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

3.0

11.8

264

R03BC03

ATC

nedocromil; inhalant

4.1

11.7

127

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.2

11.7

P01AB01

ATC

metronidazole; oral, rectal

2.1

11.7

183

1128

A28

ICPC

Limited function/disability NOS

3.2

11.7

228

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

31.0

11.7

R51.80

ICD-10 Finland

Headache

2.7

11.6

364

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

11.6

195

XG410

NOMESCO Finland

Flow-volume spirometry

5.3

11.6

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

11.5

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.9

11.5

300

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

11.0

11.4

Z50.1

ICD-10 Finland

Other physical therapy

4.8

11.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.3

11.4

204

D70.89

ICD-10 Finland

Neutropenic splenomegaly

13.2

11.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.2

11.2

223

R06AE09

ATC

levocetirizine; oral

2.6

11.2

379

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

25.8

11.2

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

7.0

11.2

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

5.8

11.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

11.0

226

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

8.2

11.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

10.9

198

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

28.9

10.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.3

10.8

194

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.8

10.8

132

J01.4

ICD-10 Finland

Acute pansinusitis

22.2

10.7

H66.0

ICD-10 Finland

Acute suppurative otitis media

3.2

10.7

205

A02BC05

ATC

esomeprazole; systemic

2.1

10.6

182

1150

UJD02

NOMESCO Finland

Gastroscopy

5.4

10.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.1

10.5

209

A02BC03

ATC

lansoprazole; oral

2.2

10.5

129

705

WX892

NOMESCO Finland

Monitored bed care

3.6

10.5

146

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

10.5

D84.1

ICD-10 Finland

Defects in the complement system

+∞

10.5

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.3

10.4

113

584

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

12.5

10.4

N06AA10

ATC

nortriptyline; systemic

9.2

10.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

10.4

211

JN4AD

NOMESCO Finland

Body CT examination

4.0

10.4

110

RD210

NOMESCO Finland

5.9

10.3

J01FA01

ATC

erythromycin; systemic

2.6

10.3

341

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

7.2

10.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.8

10.2

127

N03AX11

ATC

topiramate; oral

6.8

10.2

R53

ICD-10 Finland

Malaise and fatigue

2.4

10.2

470

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

11.7

10.1

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.2

10.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

10.1

215

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

15.1

10.1

R01AD01

ATC

beclometasone; nasal

2.6

10.1

364

H92.0

ICD-10 Finland

Otalgia

4.3

10.0

DPA30

NOMESCO Finland

Sphenotomy

41.1

10.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

10.0

163

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.9

10.0

114

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.0

9.9

104

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.3

9.9

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.5

9.9

142

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

20.6

9.9

A01AB04

ATC

amphotericin B; local oral

4.5

9.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.8

9.8

261

3AC01

NOMESCO Finland

11.8

9.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.3

9.6

N03AE01

ATC

clonazepam; systemic

3.8

9.6

113

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.1

9.5

N05CD07

ATC

temazepam; oral

2.9

9.5

235

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

18.1

9.5

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

18.1

9.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.6

9.5

ZX110

NOMESCO Finland

Intracutaneous

102.3

9.5

UJF92

NOMESCO Finland

Capsular endoscopy

8.4

9.4

602

Kela drug reimbursment

Children's severe malnutrition

30.8

9.4

GD1DG

NOMESCO Finland

Extremely extensive MRI examination of pleura with high field magnet

+∞

9.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

+∞

9.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

9.4

106

553

A02BA02

ATC

ranitidine; systemic

2.4

9.4

449

J01DA08

ATC

[U] cefaclor; oral

2.6

9.4

304

M35.7

ICD-10 Finland

Hypermobility syndrome

9.9

9.4

SPAT1324

SPAT

Screening procedure

0.3

9.2

532

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

14.1

9.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.0

9.2

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.0

9.2

208

A06AD11

ATC

lactulose; oral

2.8

9.2

241

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

9.1

110

591

4224

FHL

Endonasal anthrostomy

16.0

9.1

XG474

NOMESCO Finland

Exhalation nntrogen oxide

6.0

9.0

J32.8

ICD-10 Finland

Other chronic sinusitis

24.6

9.0

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

24.6

9.0

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

7.1

9.0

N06AA09

ATC

amitriptyline; systemic

3.0

8.9

199

N02BE01

ATC

paracetamol; systemic, rectal

2.3

8.9

343

2883

L28

ICPC

Limited function/disability (L)

2.7

8.9

272

ZYC01

NOMESCO Finland

Remote contact by phone

4.0

8.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

8.9

387

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

9.8

8.9

R49.01

ICD-10 Finland

Functional dysphonia

5.1

8.8

AA1AD

NOMESCO Finland

CT of head and brain

2.3

8.8

485

R51.81

ICD-10 Finland

Facial pain NOS

7.5

8.8

H02AB02

ATC

dexamethasone; systemic

2.8

8.8

227

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.4

8.8

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.1

8.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.4

8.7

128

C09CA06

ATC

candesartan; oral

2.3

8.7

450

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

51.1

8.7

R11

ICD-10 Finland

Nausea and vomiting

3.1

8.7

167

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

11.9

8.6

R06AX22

ATC

ebastine; oral

2.3

8.6

454

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

8.6

103

551

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

9.3

8.6

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

16.7

8.6

R01AD11

ATC

triamcinolone; nasal

3.0

8.6

192

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

28.2

8.5

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

28.2

8.5

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.1

8.4

J33.8

ICD-10 Finland

Other polyp of sinus

8.1

8.4

5BA08

NOMESCO Finland

91.8

8.4

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

8.4

155

N02CC03

ATC

zolmitriptan; nasal, oral

3.9

8.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.3

8.4

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

8.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

7.3

8.3

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.8

8.2

M01AG02

ATC

tolfenamic acid; oral, rectal

2.3

8.2

373

M03BX01

ATC

baclofen; systemic

8.4

8.2

E000002

ATC

2.6

8.1

271

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

12.0

8.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

8.1

102

RK110

NOMESCO Finland

17.6

8.1

B28

ICPC

Limited function/disability (B)

17.6

8.1

WW300

NOMESCO Finland

Transfer of autologic stem cells

17.6

8.1

H05AA02

ATC

teriparatide; parenteral

34.1

8.1

318

Kela drug reimbursment

Teriparatide

34.1

8.1

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

34.1

8.1

4222

FHL

Endonasal etmoidectomy

34.1

8.1

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.7

8.1

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.7

8.1

221

B99

ICD-10 Finland

Other and unspecified infectious diseases

10.3

8.1

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

8.1

315

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

22.5

8.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

7.5

8.0

RS220

NOMESCO Finland

7.5

8.0

Z71.8

ICD-10 Finland

Other specified counselling

2.1

8.0

111

628

H65.3

ICD-10 Finland

Chronic mucoid otitis media

5.4

8.0

J02AC02

ATC

itraconazole; systemic

2.2

7.9

445

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

13.4

7.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

7.9

161

J01.1

ICD-10 Finland

Acute frontal sinusitis

8.7

7.9

J96.0

ICD-10 Finland

Acute respiratory failure

11.1

7.8

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

11.1

7.8

JN6AD

NOMESCO Finland

CT of torso and neck

11.1

7.8

XX3DW

NOMESCO Finland

Time consuming IT work

2.9

7.8

169

XCK00

NOMESCO Finland

Perimetry

3.5

7.8

106

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

15.4

7.8

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

45.8

7.7

N06AX11

ATC

mirtazapine; oral

1.9

7.7

137

852

C07AB07

ATC

bisoprolol; oral

1.9

7.6

161

1063

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

12.2

7.6

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

10.3

7.6

TK800

NOMESCO Finland

Hemodialysis

7.3

7.6

J01

ICD-10 Finland

Acute sinusitis

3.3

7.5

120

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.7

7.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.8

7.5

196

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.8

7.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.9

7.5

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

81.5

7.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

7.4

176

1210

A04AA02

ATC

granisetron; systemic, transdermal

3.2

7.4

122

L03AA14

ATC

lipegfilgrastim; parenteral

7.0

7.4

R05CB01

ATC

acetylcysteine; inhalant, oral

11.1

7.3

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

9.6

7.3

D06BB03

ATC

aciclovir; topical

3.9

7.3

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.3

7.3

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

7.3

1XX32

NOMESCO Finland

+∞

7.3

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

7.3

D81.0

ICD-10 Finland

Severe combined immunodeficiency [SCID] with reticular dysgenesis

+∞

7.3

J06BA02

ATC

immunoglobulins, normal human, for intravascular adm.; systemic

+∞

7.3

2AX04

NOMESCO Finland

+∞

7.3

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

16.1

7.3

R06AX13

ATC

loratadine; oral

2.1

7.3

434

M05BB03

ATC

alendronic acid and colecalciferol; oral

7.5

7.3

C10AC01

ATC

colestyramine; oral

5.2

7.2

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.7

7.2

G93.3

ICD-10 Finland

Postviral fatigue syndrome

30.6

7.2

TK810

NOMESCO Finland

Hemofiltration

30.6

7.2

C08DA01

ATC

verapamil; systemic

4.5

7.2

J01CA04

ATC

amoxicillin; systemic

2.0

7.1

339

2905

M01AH01

ATC

celecoxib; oral (coxibs)

2.2

7.1

385

S97

ICPC

Chronic ulcer skin

4.0

7.1

A41.8

ICD-10 Finland

Other specified sepsis

9.0

7.1

L04AA01

ATC

[U] ciclosporin; systemic

9.0

7.1

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.7

7.0

193

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.2

7.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.1

7.0

R49.08

ICD-10 Finland

Other specified dysphonia

6.0

7.0

B03XA02

ATC

darbepoetin alfa; parenteral

7.7

7.0

R96

ICPC

Asthma

2.7

7.0

176

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.8

6.9

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.9

6.9

152

SPAT1262

SPAT

Handing over of treatment supplies

2.2

6.9

403

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

8.5

6.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

6.9

216

XF404

NOMESCO Finland

Ambulatory ECG

2.7

6.9

189

M01AH02

ATC

rofecoxib; oral

2.4

6.9

261

A46

ICD-10 Finland

Erysipelas

2.4

6.9

261

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.3

6.9

106

TQW99

NOMESCO Finland

Other minor procedure on skin

3.7

6.8

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

9.5

6.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

9.5

6.8

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

9.5

6.8

R13

ICD-10 Finland

Dysphagia

3.2

6.8

112

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

6.8

438

TKC20

NOMESCO Finland

Catheterisation of bladder

3.1

6.8

118

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.9

6.8

115

699

QXB99

SPAT

40.7

6.8

DPA20

NOMESCO Finland

Trephine of frontal sinus

40.7

6.8

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

40.7

6.8

RS230

NOMESCO Finland

17.0

6.8

J05AH02

ATC

oseltamivir; oral

17.0

6.8

EB1WA

NOMESCO Finland

17.0

6.8

C82.1

ICD-10 Finland

Follicular lymphoma grade II

17.0

6.8

R05FB02

ATC

cough suppressants and expectorants

1.8

6.8

145

955

A03FA02

ATC

cisapride; oral, rectal

3.0

6.8

134

G44.2

ICD-10 Finland

Tension-type headache

2.3

6.8

327

H66.9

ICD-10 Finland

Otitis media, unspecified

2.8

6.7

158

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

6.7

122

759

K29.3

ICD-10 Finland

Chronic superficial gastritis

5.3

6.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.9

6.7

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

22.9

6.7

C83.1

ICD-10 Finland

Mantle cell lymphoma

22.9

6.7

YNB10

NOMESCO Finland

Collection of stem cells for transplant

22.9

6.7

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

6.7

119

736

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.4

6.7

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

6.1

6.7

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

6.7

103

604

R4190

NOMESCO Finland

Nutritional therapy

3.7

6.6

M79.6

ICD-10 Finland

Pain in limb

1.8

6.6

149

994

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

12.5

6.6

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

12.5

6.6

M05BX04

ATC

denosumab; parenteral

3.8

6.6

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.1

6.6

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

5.2

6.6

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.2

6.6

P01BA02

ATC

hydroxychloroquine; oral

2.7

6.6

170

L03AA13

ATC

pegfilgrastim; parenteral

3.5

6.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

7.6

6.5

RS231

NOMESCO Finland

70.9

6.4

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

70.9

6.4

K12.10

ICD-10 Finland

Stomatitis NOS

70.9

6.4

DMB10

NOMESCO Finland

Radical maxillary antrotomy

14.6

6.4

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

14.6

6.4

RK320

NOMESCO Finland

14.6

6.4

J32.1

ICD-10 Finland

Chronic frontal sinusitis

14.6

6.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

6.4

196

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

4.1

6.4

A07EA06

ATC

budesonide; oral, local oral

4.1

6.4

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.3

6.4

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.0

6.4

Z50.5

ICD-10 Finland

Speech therapy

6.7

6.4

A12AA04

ATC

calcium carbonate; oral

8.3

6.4

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

8.3

6.4

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

6.4

178

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.7

6.4

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

11.3

6.3

GBB00

NOMESCO Finland

Tracheostomy

11.3

6.3

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.5

6.3

N06AX17

ATC

milnacipran; oral

9.5

6.3

RS224

NOMESCO Finland

9.5

6.3

M54.2

ICD-10 Finland

Cervicalgia

3.0

6.3

119

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

18.3

6.3

J05AB09

ATC

famciclovir; oral

18.3

6.3

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

18.3

6.3

D83.1

ICD-10 Finland

Common variable immunodeficiency with predominant immunoregulatory T-cell disorders

+∞

6.3

D84.8

ICD-10 Finland

Other specified immunodeficiencies

+∞

6.3

D83.8

ICD-10 Finland

Other common variable immunodeficiencies

+∞

6.3

Z94.2

ICD-10 Finland

Lung transplant status

+∞

6.3

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

6.3

2AA01

NOMESCO Finland

+∞

6.3

4AA24

NOMESCO Finland

+∞

6.3

DHB50

NOMESCO Finland

Turbinoplasty

4.6

6.2

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.7

6.2

173

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

5.5

6.2

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.4

6.2

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

5.9

6.2

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.9

6.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

6.2

202

K07.60

ICD-10 Finland

Snapping jaw

3.3

6.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

6.2

139

J01EA01

ATC

trimethoprim; systemic

1.9

6.1

101

606

N06AX16

ATC

venlafaxine; oral

2.2

6.1

340

R42

ICD-10 Finland

Dizziness and giddiness

2.0

6.1

503

E000001

ATC

1.9

6.1

526

D07AA02

ATC

hydrocortisone; topical

2.1

6.1

356

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.0

6.1

WX402

NOMESCO Finland

General anaesthesia

2.0

6.1

453

B01AB05

ATC

enoxaparin; parenteral

1.8

6.1

113

706

B00.10

ICD-10 Finland

Herpes simplex facialis

12.8

6.1

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

12.8

6.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

6.1

434

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.9

6.1

127

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.2

6.1

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3028026) IgM [Mass/volume] in Serum or Plasma

303

246

37.17

307.65

5.0

1.7

g/l

0.8

1.5

3.31

282

230

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

170

153.06

307.65

3.0

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

164

144.46

307.65

2.9

1.4

12.4

9.3

0.98

110

(3011412) CD3 cells [#/volume] in Blood

179

96.51

307.65

2.9

1.4

e9/l

1.4

1.6

0.48

138

(4062490)

142

56.13

240.63

2.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

142

56.13

240.63

2.2

1.4

g/l

0.2

0.3

1.01

117

(3028192) IgG subclass 2 [Mass/volume] in Serum

142

56.13

240.63

2.2

1.4

g/l

1.7

2.7

2.19

116

(3027135) IgG subclass 1 [Mass/volume] in Serum

142

56.13

240.63

2.2

1.4

g/l

4.5

6.7

4.52

118

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

132

69.35

235.67

2.8

1.3

e6/l

578.7

712.4

0.41

105

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

128

68.95

228.61

2.9

1.3

e9/l

0.2

0.38

105

(3024980) IgG subclass 4 [Mass/volume] in Serum

145

34.35

211.03

2.2

1.5

g/l

0.3

0.7

3.95

118

(3000060) B lymphocytes [#/volume] in Blood

103

89.29

193.78

2.9

1.7

e6/l

742.0

340.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

109

47.93

180.39

2.7

1.6

e6/l

706.8

714.4

0.02

(3005322) IgE [Units/volume] in Serum or Plasma

185

254

11.82

139.08

2.0

1.2

u/ml

50.9

222.5

1.18

142

233

(3007164) IgA [Mass/volume] in Serum or Plasma

320

870

10.76

132.14

5.2

1.4

g/l

1.2

2.2

19.71

264

540

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

67.98

124.78

1.2

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

66.82

122.60

1.2

1.1

95.4

89.4

0.22

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

183

336

8.60

105.25

4.1

2.6

g/l

0.2

2.81

183

319

(42870588) Differential panel, method unspecified - Blood

346

1211

9.62

104.82

19.3

5.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

16.12

98.57

6.6

8.6

iu/ml

532.5

193.3

0.60

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

114

132

11.30

94.87

1.8

1.6

g/l

0.2

0.25

102

127

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

116

140

10.89

93.58

1.8

1.5

g/l

1.1

1.2

0.61

107

134

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

0.8

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

1.5

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

2.6

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

1.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

0.7

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

1.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

0.6

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

2.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

+∞

93.09

1.9

0.0

mg/l

1.2

—

(3023419) Bacteria identified in Sputum by Culture

20.79

90.65

4.1

2.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

+∞

88.59

1.5

0.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

169

338

7.49

88.12

2.7

1.8

—

(3001604) Monocytes [#/volume] in Blood

398

1851

12.80

82.56

22.4

5.9

e9/l

0.6

0.44

388

1592

(3006315) Basophils [#/volume] in Blood

398

1857

12.72

82.07

22.4

5.9

e9/l

0.0

0.16

388

1594

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

164

341

7.06

81.69

2.8

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

15.08

81.54

5.5

4.7

u/ml

7644.4

4287.8

—

(3019198) Lymphocytes [#/volume] in Blood

399

1903

12.52

79.16

22.6

5.9

e9/l

2.0

0.02

393

1671

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

192

484

6.25

77.75

3.2

1.9

—

(3013115) Eosinophils [#/volume] in Blood

398

1912

12.09

77.71

23.9

6.3

e9/l

0.2

2.10

393

1677

(40758558) Short blood count panel - Blood

268

918

5.89

76.14

19.3

6.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

128

220

7.79

76.12

3.1

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

11.59

72.08

2.7

3.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

10.80

68.54

2.8

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

12.81

67.59

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

12.81

67.59

1.5

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

10.52

66.48

2.6

1.8

—

(3023368) Bacteria identified in Blood by Culture

236

797

5.22

66.13

9.9

4.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

125

241

6.84

65.96

4.3

2.7

g/l

61.5

67.3

10.09

120

223

(3013650) Neutrophils [#/volume] in Blood by Automated count

399

2145

10.03

62.06

31.7

9.2

e9/l

3.8

4.0

0.62

394

1865

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

11.64

61.75

2.6

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

11.88

58.37

2.3

1.7

—

(3021589) Normoblasts [#/volume] in Blood

339

1678

5.41

54.96

28.7

8.9

e9/l

0.0

0.11

314

1342

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

13.53

54.95

2.2

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

104

199

6.53

54.65

4.1

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

16.85

54.47

4.6

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

11.08

53.99

1.9

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

154

424

5.04

53.89

2.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

14.29

53.76

2.3

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

11.97

53.47

2.2

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

154

434

4.92

52.18

4.0

2.3

22.0

23.6

0.58

146

377

(21494814) CD8 cells/100 lymphocytes in Specimen

125.32

52.11

2.8

1.8

—

(3042936) Bacteria identified in Isolate by Culture

164

491

4.73

51.40

3.2

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

120.15

50.00

3.0

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

9.02

47.65

1.7

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

15.26

47.40

2.0

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

149

6.63

46.11

3.0

1.6

—

(3018418) pH of Serum or Plasma

238

997

4.01

46.02

10.2

3.7

7.4

0.62

183

(3000494) Fungus identified in Specimen by Culture

147

437

4.55

45.89

2.6

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

209

806

4.03

45.48

3.2

2.1

mg/l

2.9

3.0

0.33

198

689

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

303

1522

4.17

44.31

20.4

6.3

mmol/l

1.2

2.66

293

1390

(3000492) Spirometry study

132

371

4.65

44.12

2.9

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

109

7.32

43.19

3.0

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

298

1497

4.06

43.16

4.7

2.4

nmol/l

83.7

76.0

4.33

290

1349

(3024891) Influenza virus A+B Ag [Presence] in Specimen

108

7.26

42.32

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

100

7.45

41.63

5.2

2.7

g/l

0.3

0.8

0.71

(46235355) HIV 1 and 2 tests - Meaningful Use set

194

750

3.83

41.31

2.3

1.9

—

(36304419) Bacteria [Presence] in Urine

220

938

3.68

40.12

5.8

2.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

6.87

39.67

5.5

2.3

g/l

3.1

0.06

(3030467) Casts [#/volume] in Urine by Automated count

220

946

3.65

39.44

5.9

3.0

e6/l

0.2

0.5

2.45

185

704

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

6.63

39.32

5.4

2.2

g/l

3.0

3.7

4.24

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

6.63

39.32

5.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

6.63

39.32

5.4

2.2

g/l

7.3

7.4

0.09

(3045142) Bone marrow Pathology biopsy report

11.24

39.27

1.9

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

123

359

4.36

38.69

7.3

3.1

2.0

1.7

1.09

115

333

(3037756) Immunofixation for Serum or Plasma

9.50

38.59

1.7

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

100

249

4.90

38.48

5.7

3.0

e9/l

75.7

75.5

0.02

181

(3026782) Osmolality of Urine

177

675

3.71

37.91

5.5

2.6

mosm/kgh2o

506.5

557.6

2.39

165

584

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

308

1669

3.80

37.84

19.9

6.9

mmol/l

1.2

0.89

274

1425

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

7.77

37.78

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

8.00

36.84

7.8

4.4

mg/l

18.9

26.6

1.05

(3034860) Kappa light chains.free [Mass/volume] in Serum

8.00

36.84

7.8

4.4

mg/l

35.9

140.7

0.65

(44806118)

10.25

36.82

2.1

1.7

—

(44790048)

10.25

36.82

2.1

1.7

—

(44790047)

10.25

36.82

2.1

1.7

—

(44790049)

10.25

36.82

2.1

1.7

—

(3018095) Leukocytes [#/volume] in Urine

255

1243

3.49

36.73

6.9

3.6

e6/l

23.8

63.2

2.28

198

857

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

6.57

36.48

5.5

2.3

g/l

6.8

10.1

7.65

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

248

1200

3.44

35.93

6.5

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

179

708

3.57

35.92

5.2

2.6

e6/l

3.8

5.5

1.97

166

625

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

9.82

35.67

3.9

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

151

537

3.76

35.63

13.2

4.2

mmol/l

0.8

0.45

146

508

(3036481) Cortisol [Moles/volume] in Serum or Plasma

120

364

4.16

35.57

3.3

1.9

nmol/l

312.4

364.9

1.86

111

343

(3042111) Morphology [Interpretation] in Bone marrow Narrative

9.47

35.49

2.3

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

146

510

3.78

35.35

2.6

2.3

ug/g

147.5

122.5

0.28

122

401

(3024561) Albumin [Mass/volume] in Serum or Plasma

274

1422

3.45

35.11

12.1

4.7

g/l

34.7

36.4

4.58

268

1344

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

6.80

35.03

5.2

2.4

g/l

38.8

38.7

0.06

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

10.17

34.99

2.6

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

9.29

34.96

2.6

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

10.37

34.67

4.1

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

224

1036

3.36

34.64

6.2

3.1

e6/l

22.0

64.4

1.77

188

790

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

317

1814

3.66

34.34

12.4

6.4

umol/l

10.0

10.8

0.77

312

1716

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

12.18

33.97

3.5

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

9.05

33.54

7.7

5.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

11.79

33.28

3.5

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

402

2743

6.26

32.92

22.4

7.3

u/l

83.8

80.5

0.78

396

2567

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

12.66

32.88

1.7

1.2

u/ml

0.3

0.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

399

2717

5.92

32.48

13.6

4.0

mm/h

12.7

10.6

2.00

394

2502

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

5.66

32.12

2.9

1.2

u/l

41.7

37.6

0.75

119

(3002179) Metamyelocytes/100 leukocytes in Blood

276

4.17

30.27

9.1

4.6

0.7

0.5

0.68

(3017181) Myelocytes/100 leukocytes in Blood

294

4.05

29.83

10.2

4.8

1.1

0.8

0.43

(3021440) Promyelocytes/100 leukocytes in Blood

274

4.14

29.80

10.3

5.0

0.3

0.1

1.09

(3028433) Virus identified in Specimen by Culture

13.52

29.13

2.1

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

118

5.62

28.86

2.7

2.6

g/l

1.3

1.5

0.33

103

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

117

406

3.56

27.92

3.9

3.5

umol/l

6.1

6.7

0.21

107

353

(3025159) Blasts/100 leukocytes in Blood

264

4.03

27.45

10.4

5.0

0.1

0.0

0.12

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

6.97

27.43

8.2

3.8

56.8

56.3

0.07

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

11.43

27.15

1.9

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

240

1291

2.88

26.37

2.6

1.9

pmol/l

96.8

96.9

0.02

147

657

(3001122) Ferritin [Mass/volume] in Serum or Plasma

278

1620

2.94

26.18

5.4

2.7

ug/l

200.5

98.3

2.10

270

1502

(3000991) Gas panel - Venous blood

295

3.78

25.95

22.4

8.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

6.88

24.79

3.0

2.0

g/l

125.9

130.3

0.24

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

13.30

24.78

2.6

3.5

umol/l

28.1

29.4

0.15

(3014111) Lactate [Moles/volume] in Serum or Plasma

262

3.84

24.72

19.7

7.7

mmol/l

1.2

1.3

0.12

249

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

14.22

24.69

2.8

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

171

790

2.90

24.69

3.5

1.9

mg/l

1.6

1.1

0.52

142

606

(3037522) Nuclear Ab [Titer] in Serum

131

527

3.11

24.20

1.7

1.4

titre

570.4

489.1

0.23

114

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

13.43

23.89

2.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

122

476

3.16

23.70

2.0

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

12.72

23.13

2.8

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

311

2005

2.87

22.79

13.6

4.8

mmol/l

6.6

0.08

301

1861

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

5.32

22.58

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

141

615

2.90

22.31

2.0

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

10.54

22.24

2.6

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

6.01

21.73

2.5

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

12.13

21.50

1.7

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

6.56

21.45

1.7

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

17.02

21.22

1.8

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

130

560

2.87

20.88

3.9

2.7

e6/l

1.6

0.9

1.16

306

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

125

531

2.89

20.57

4.1

2.9

e6/l

2.9

2.5

0.15

278

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

14.14

20.34

1.8

1.6

—

(40768797) Stomach Pathology biopsy report

117

490

2.89

19.67

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

14.39

19.45

1.4

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

14.39

19.45

2.9

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

168

3.98

19.24

1.8

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

5.46

19.20

3.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

9.01

19.06

1.5

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

153

749

2.60

18.84

2.0

1.4

nmol/l

23.6

21.7

0.56

142

632

(3021879) Hepatitis B virus core Ab [Presence] in Serum

304

3.22

18.79

1.6

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

164

832

2.55

18.73

5.0

2.9

ng/l

1416.0

926.4

0.75

152

685

(3037467) Urinalysis macro (dipstick) panel - Urine

344

2467

2.79

18.25

8.1

4.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

201

3.62

18.04

23.8

4.6

mmol/l

24.1

0.06

192

(3025941) Bacteria identified in Stool by Culture

222

3.50

18.03

1.7

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

5.06

17.64

1.8

1.4

—

(4035726)

298

3.15

17.58

2.2

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

330

3.00

16.74

2.7

2.6

u/l

28.9

33.8

0.45

279

(21494434) Karyotype in Bone marrow

8.03

16.70

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

7.63

16.68

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

5.14

16.67

1.9

1.4

u/ml

85.2

110.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

383

2.85

16.38

17.2

7.1

mmol/l

104.1

0.00

373

(3051611) Lipemic interference index of Serum or Plasma

7.41

16.26

3.3

3.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

180

1003

2.34

16.23

3.5

2.1

u/l

112.1

184.0

1.84

173

945

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

9.88

16.22

1.7

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

120

4.16

16.18

1.3

1.1

—

(3003396) Base excess in Arterial blood by calculation

318

2.98

16.17

14.9

9.9

mmol/l

1.0

1.2

0.19

251

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

169

3.65

16.06

2.2

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

4.83

15.95

2.0

1.5

—

(4010399)

269

3.10

15.78

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

5.68

15.64

1.6

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

192

1115

2.28

15.55

5.4

2.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.74

15.54

2.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.74

15.54

2.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.74

15.54

2.8

1.7

—

(3002032) Base excess in Venous blood by calculation

326

2.90

15.42

20.1

4.5

mmol/l

1.8

2.1

0.20

254

(3011397) Hemoglobin [Presence] in Urine by Test strip

151

794

2.37

15.42

4.2

3.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

120

4.06

15.36

1.5

1.3

—

(3042631) Mycobacterium sp identified in Specimen

6.36

15.29

3.7

2.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

6.57

15.17

1.7

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

5.48

15.07

1.6

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

4.69

15.01

6.3

4.0

u/ml

0.4

0.03

(3051651) Icteric interference index of Serum or Plasma

8.33

15.00

3.3

3.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

6.08

14.63

4.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

6.08

14.63

4.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

6.08

14.63

4.3

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

195

1166

2.21

14.44

5.5

3.3

mmol/l

2.3

2.4

2.52

175

1029

(3026493) Urate [Moles/volume] in Serum or Plasma

160

884

2.27

14.38

6.9

2.7

umol/l

326.1

5654.0

3.08

146

769

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

4.28

14.11

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

5.96

13.82

4.4

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

5.96

13.82

4.4

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

261

1774

2.15

13.67

7.5

4.7

estimate

0.0

0.00

352

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

193

3.24

13.63

4.4

2.8

ng/l

240.8

162.2

0.39

179

(3032080) INR in Blood by Coagulation assay

203

1256

2.14

13.56

8.3

7.7

inr

1.1

1.2

0.45

394

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

118

585

2.39

13.54

5.1

3.4

ng/l

108.5

237.9

1.05

414

(3005988) Vibrio sp identified in Specimen by Organism specific culture

5.83

13.51

4.4

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

3.54

13.43

1.7

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

13.36

13.42

2.4

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

13.36

13.42

5.2

5.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

5.36

13.33

1.4

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

7.18

13.24

3.0

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

100

4.06

13.18

3.9

2.0

ug/l

213.6

285.6

0.36

(3022145) Colonoscopy Study observation

400

2.57

13.03

1.5

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

115

3.83

13.03

1.6

1.4

ug/g

363.4

319.1

0.64

(3009261) Glucose [Presence] in Urine by Test strip

261

1796

2.11

12.96

5.7

3.4

estimate

0.0

0.50

338

(3035350) Ketones [Presence] in Urine by Test strip

258

1771

2.10

12.85

5.7

3.4

estimate

0.0

0.00

345

(3009871) Measles virus Ab [Titer] in Serum

12.15

12.69

2.6

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

111

551

2.36

12.61

1.9

1.7

nmol/l

1298.0

1220.6

0.33

415

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

328

2.67

12.61

4.5

3.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

+∞

12.56

1.8

0.0

—

(3026008) Bacteria identified in Urine by Culture

169

1002

2.11

12.35

4.4

2.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

150

3.39

12.33

20.7

13.7

—

(40768804) Tissue Pathology biopsy report

222

1457

2.05

12.31

2.7

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

4.01

11.70

1.8

1.4

u/ml

139.7

236.4

1.53

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

147

843

2.12

11.60

4.9

2.1

—

(40768795) Lymph node Pathology biopsy report

5.60

11.46

1.8

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

148

860

2.09

11.21

15.5

4.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

9.00

11.17

1.9

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

9.00

11.17

1.9

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

425

3718

4.94

10.89

50.8

12.2

mg/l

18.8

21.2

1.19

404

2838

(21494890) Protein electrophoresis panel - 24 hour Urine

6.76

10.71

4.8

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

4.27

10.58

3.7

1.6

—

(3047189) Immunofixation for 24 hour Urine

10.25

10.48

4.4

2.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

139

3.23

10.39

1.8

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

3.68

10.39

1.5

1.4

iu/ml

1.8

0.0

0.47

(3037121) Protein [Mass/volume] in Urine

129

3.31

10.31

3.4

4.6

g/l

0.2

0.3

0.50

(3015171) Extractable nuclear Ab [Units/volume] in Serum

140

3.21

10.27

1.6

1.3

u/ml

0.5

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

5.20

10.14

3.0

3.5

u/ml

51.3

50.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

6.60

9.87

1.3

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

7.02

9.79

2.5

2.7

ug/l

75.9

120.3

0.56

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

4.61

9.66

1.4

1.3

—

(40768446) Kidney Pathology biopsy report

10.23

9.58

2.4

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

384

3229

2.46

9.54

55.0

15.0

14.1

13.5

8.10

384

3176

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

18.02

9.46

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

6.72

9.41

3.5

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

6.72

9.41

3.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

6.72

9.41

3.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

6.72

9.41

3.5

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

6.11

9.18

1.1

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

133

3.12

9.18

1.4

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.55

9.08

1.5

1.2

u/ml

3.4

0.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

134

3.10

9.06

1.4

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

6.43

9.05

1.1

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

7.41

8.89

1.6

1.8

umol/l

10.6

10.8

0.05

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.82

8.86

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

5.17

8.69

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

5.17

8.69

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

5.17

8.69

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

10.21

8.67

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

5.69

8.56

1.6

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

105

587

2.04

8.54

3.4

2.6

mmol/l

2.4

0.07

517

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

7.02

8.48

3.8

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

7.02

8.48

3.0

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

7.02

8.48

3.0

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.02

8.48

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

7.02

8.48

3.8

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

7.02

8.48

3.8

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

134

3.01

8.45

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

5.03

8.43

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

5.03

8.43

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

5.03

8.43

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

5.94

8.38

1.3

1.0

—

(40768443) Skin Pathology biopsy report

147

2.89

8.27

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

3.29

8.12

1.5

1.2

u/ml

7.8

33.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

17.58

8.11

3.2

5.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

4.41

8.02

1.5

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

122

3.03

7.94

1.4

1.2

u/ml

1.2

7.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

161

1061

1.81

7.88

3.7

2.5

u/l

54.0

55.8

0.31

156

981

(3008757) Leukocyte morphology finding [Identifier] in Blood

4.32

7.81

7.1

3.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

6.35

7.75

1.2

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

4.11

7.70

1.1

—

(3024928) Oxygen saturation in Venous blood

3.62

7.66

30.4

3.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3.44

7.65

4.9

3.3

mmol/l

24.5

24.8

0.11

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

112

665

1.92

7.58

1.3

iu/ml

29.0

35.5

0.30

209

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

248

2.39

7.58

15.4

4.1

mmol/l

1.3

1.6

0.24

176

(3019060) Gas panel - Arterial blood

179

2.62

7.52

8.4

7.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

4.74

7.46

2.0

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

13.66

7.42

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

16.06

7.26

2.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

4.06

7.24

2.9

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

2.86

7.21

1.5

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.03

7.18

1.7

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

7.03

7.18

1.1

miu/ml

784.2

1648.6

1.64

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.85

7.14

1.1

1.2

—

(3044889) 12 lead EKG panel

304

2452

1.77

7.03

4.7

3.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

5.32

7.01

4.4

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

6.14

6.94

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

3.57

6.93

1.2

—

(3009343) pH of Capillary blood

259

2.28

6.86

15.7

4.0

7.4

0.47

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

388

3394

2.19

6.85

35.7

11.2

ml/min/173m2

87.5

85.7

0.81

370

2730

(3023410) Appearance of Cerebral spinal fluid

4.38

6.81

5.2

1.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

6.61

6.80

4.3

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.37

6.65

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

220

1642

1.68

6.60

8.0

3.9

—

(3021901) Oxygen saturation in Capillary blood

3.93

6.60

5.0

3.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

3.33

6.52

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

3.33

6.52

1.3

1.1

—

(1616796) Gas panel - Central venous blood

3.63

6.52

9.3

2.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

6.24

6.46

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

324

2694

1.76

6.38

4.9

3.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

4.33

6.34

4.4

1.8

32.8

32.7

0.04

(3022806) Fractional oxyhemoglobin in Capillary blood

4.33

6.34

2.9

1.9

90.1

89.4

0.18

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

6.80

6.33

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

6.80

6.33

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

3.95

6.32

3.7

1.9

mmol/l

1.5

1.6

0.34

(36660697) Celiac disease serology panel - Serum

340

2.07

6.24

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

3.63

6.23

6.5

2.5

16.1

16.2

0.01

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

4.22

6.14

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.91

6.13

1.0

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

173

1231

1.67

6.11

5.0

3.2

ng/l

24.5

29.6

0.40

117

768

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

3.35

6.08

5.6

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.40

6.07

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

160

2.50

6.07

2.4

2.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

4.63

6.02

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

128

843

1.73

6.01

2.0

1.6

—

(21494755) Public health laboratory ask at order entry panel

449

0.27

5.91

1.2

1.4

—

(3017732) Neutrophils [#/volume] in Blood

228

2.24

5.87

3.2

2.8

e9/l

4.0

4.1

0.06

185

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

4.49

5.80

1.6

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

3.34

5.80

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.44

5.79

1.9

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

133

2.60

5.76

2.4

1.7

u/l

9.3

9.9

0.07

106

(3002256) Pathology report gross observation

456

1.89

5.72

1.4

1.2

—

(40757373) Influenza virus identified in Isolate

13.09

5.60

1.2

2.1

—

(3044941) Cell count panel - Synovial fluid

3.92

5.58

2.1

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

102

642

1.77

5.57

1.3

u/ml

7.0

10.8

0.29

252

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

16.25

5.43

5.6

5.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

16.25

5.43

5.0

6.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.66

5.34

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.95

5.30

2.1

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

3.43

5.22

1.4

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.36

5.06

1.5

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

140

985

1.62

4.98

1.4

u/ml

0.5

1.7

3.47

277

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

113

2.58

4.90

5.7

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

9.16

4.80

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.88

4.78

1.4

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

3.42

4.65

1.0

1.3

nmol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

135

955

1.60

4.64

7.0

3.6

estimate

0.0

0.00

345

(3019832) Treponema pallidum Ab [Presence] in Serum

393

1.83

4.59

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

274

1.97

4.55

2.7

2.4

ml/min/173m2

70.2

73.3

0.14

115

(3004716) Salmonella sp identified in Stool by Organism specific culture

231

2.06

4.54

1.4

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.67

4.52

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.08

4.46

4.6

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

3.09

4.45

1.2

1.3

u/ml

1.8

3.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.63

4.37

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.63

4.37

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

4.63

4.32

1.0

—

(3012441) Differential panel - Pleural fluid

4.63

4.32

2.2

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

11.83

4.29

1.7

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.22

4.25

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

145

1062

1.54

4.23

4.3

3.3

mmol/l

6.5

7.7

3.05

134

899

(1761868) Lipid panel - Serum or Plasma

1393

0.62

4.22

2.8

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

3.49

4.22

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

312

1.87

4.18

8.3

3.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

4.15

4.18

3.0

5.7

99.3

97.0

0.05

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.04

4.18

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

3.16

4.12

1.8

1.5

—

(3020891) Body temperature

117

2.39

4.10

7.6

5.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.01

4.05

1.2

u/ml

1.3

—

(3025130) Human papilloma virus identified in Specimen

3.01

4.05

1.9

1.8

—

(4268621)

3.33

3.94

2.2

2.1

—

(3035880) pH of Pleural fluid

7.38

3.87

2.0

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

332

2922

1.55

3.83

5.3

4.0

pmol/l

14.8

14.6

0.76

319

2679

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

12.14

3.77

1.8

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

12.14

3.77

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

12.14

3.77

1.8

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

12.14

3.77

2.0

1.2

umol/l

17.0

16.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

12.14

3.77

1.8

1.0

—

(40761511) CBC panel - Blood by Automated count

418

3922

2.26

3.73

31.3

11.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

133

979

1.51

3.72

1.7

mmol/l

1.4

0.07

125

835

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.77

3.69

1.6

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

6.77

3.69

2.0

1.3

u/l

13.5

13.0

—

(1002224) Polysomnography panel

179

2.04

3.60

1.1

—

(3042733) HLA Ab [Presence] in Serum

7.88

3.57

5.0

2.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.88

3.57

1.7

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

6.24

3.51

1.1

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

6.24

3.51

1.6

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

6.24

3.51

1.3

1.5

nmol/l

123.9

159.1

—

(3033799) Differential panel - Peritoneal fluid

10.11

3.50

3.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

10.11

3.50

1.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

683

1.56

3.50

2.0

1.7

pmol/l

505.4

449.5

1.01

563

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

141

2.13

3.40

1.3

miu/ml

226.4

251.6

0.15

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.09

3.37

1.7

1.0

—

(3024932) HLA-DR beta [Type]

7.09

3.37

1.1

—

(40758292) HTLV I+II Ab panel - Serum

7.09

3.37

1.0

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.80

3.35

2.5

3.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

3.08

3.27

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

374

3423

1.61

3.22

6.1

4.8

mu/l

1.8

2.2

0.53

364

3168

(3011648) Oxygen content in Venous blood

3.39

3.21

30.1

4.0

9.7

12.1

1.34

(3017704) Immunofixation for Urine

5.41

3.20

2.1

1.8

—

(3024471) HLA-A [Type]

6.45

3.19

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.45

3.19

1.0

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.86

3.11

2.7

1.3

ug/l

16.0

3.4

0.65

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

7.58

3.06

1.2

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.07

3.06

2.4

1.3

mg/l

61.5

88.3

—

(3045788) Cell count panel - Pleural fluid

5.07

3.06

1.4

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

5.91

3.03

5.4

4.4

35.2

51.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.09

2.98

1.4

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.20

2.95

1.1

—

(40768806) Pleura Pathology biopsy report

4.15

2.89

2.6

1.9

—

(3012516) Albumin [Mass/volume] in Urine

122

923

1.44

2.89

4.5

3.2

mg/l

1546.1

361.1

0.79

578

(3041096) Erythrocytes [Presence] in Urine by Automated

132

1015

1.43

2.86

6.1

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

289

2537

1.40

2.86

5.2

3.2

u/l

61.4

43.3

2.23

280

2395

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

3.28

2.79

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

8.41

2.75

1.2

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

8.41

2.75

1.2

1.0

—

(3048879) Bone marrow aspiration report

8.41

2.75

1.2

3.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.06

2.74

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.06

2.74

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

3.02

2.71

4.5

2.9

mu/l

13.4

14.7

0.15

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.81

2.68

1.2

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

170

1381

1.38

2.64

6.6

3.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

186

1.84

2.61

22.2

4.3

mmol/l

24.0

24.5

0.46

179

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.72

2.60

1.4

1.3

—

(4015189)

7.21

2.55

1.6

3.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

123

2.01

2.50

4.8

2.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

3.51

2.49

1.7

1.8

g/l

0.9

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

514

1.50

2.47

2.6

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.05

2.41

1.8

1.0

—

(3024263) Appearance of Synovial fluid

5.05

2.41

1.2

1.5

—

(40765096) Chromosome analysis panel by Banding

6.31

2.37

1.6

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.52

2.28

1.5

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.66

2.28

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.66

2.28

1.5

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.60

2.22

2.4

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

221

1.68

2.17

2.4

2.0

—

(3022313) Gas panel - Capillary blood

206

1.70

2.15

21.9

4.2

—

(3045414) Leukocytes [Presence] in Urine

138

1.86

2.14

2.6

1.6

—

(4034850)

117

1.93

2.10

17.7

9.2

—

(3022229) Phosphate [Moles/volume] in Urine

5.04

2.07

1.0

3.8

mmol/l

23.3

17.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

3.54

2.06

1.6

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

3.54

2.06

5.1

6.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

2.18

2.00

2.2

1.1

iu/ml

50.5

31.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

114

1.88

1.90

2.0

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

120

966

1.33

1.89

5.5

4.0

mg/mmol

22.5

9.1

1.21

595

(3020961) Endomysium IgA Ab [Titer] in Serum

238

1.61

1.89

1.1

1.2

—

37.6

—

(4027681)

3.22

1.88

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.98

1.88

1.5

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

411

0.58

1.87

10.1

5.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.56

1.84

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

281

1.55

1.82

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

476

1.43

1.82

2.5

2.0

—

(3044927) Protein electrophoresis panel - Urine

2.79

1.80

1.1

—

(3018133) Calcium [Moles/volume] in Urine

3.36

1.75

2.5

3.1

mmol/l

2.1

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

1.56

1.75

3.1

2.3

nmol/l

13.6

13.9

0.08

227

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.53

1.75

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

377

0.59

1.71

1.9

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

3.19

1.66

3.0

1.6

177.3

124.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.60

1.62

1.2

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

3.60

1.62

1.6

3.6

u/l

180.2

215.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.60

1.62

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

2.72

1.58

1.3

—

(44813793)

2.62

1.52

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

148

1.66

1.47

1.8

1.5

mu/l

294.3

283.6

0.12

136

(3032773) Endomysium IgG Ab [Titer] in Serum

2.14

1.45

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

122

1019

1.27

1.44

1.8

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.75

1.44

4.3

3.8

—

(3004616) Nuclear Ab [Presence] in Serum

2.06

1.34

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

302

1.43

1.33

1.9

1.3

iu/ml

94.4

153.7

0.74

128

(3008898) HLA-B27 [Presence]

177

1.56

1.32

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.87

1.31

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

323

1.40

1.26

4.0

4.1

ug/l

36.0

21.1

0.17

267

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

417

0.67

1.25

2.0

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.24

1.25

1.0

1.2

—

72.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.02

1.24

1.1

1.4

—

(3045424) Erythrocytes [Presence] in Urine

1.99

1.23

2.5

1.4

—

(4306422)

2.06

1.23

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

234

1.44

1.15

2.3

2.2

ug/l

6.2

5.8

0.07

205

(3014051) Protein [Presence] in Urine by Test strip

1.89

1.08

3.2

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

147

0.54

1.05

1.3

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.69

1.05

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.82

0.99

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

473

1.29

0.98

1.8

1.6

—

(3007461) Platelets [#/volume] in Blood

427

4189

1.61

0.96

64.0

18.1

e9/l

249.1

255.9

1.05

427

4080

(3024731) MCV [Entitic volume]

427

4191

1.59

0.93

63.6

18.0

90.4

0.04

427

4136

(3035941) MCH [Entitic mass]

427

4191

1.59

0.93

63.6

18.0

29.9

30.1

1.39

427

4135

(3026361) Erythrocytes [#/volume] in Blood

427

4192

1.59

0.91

63.9

18.1

e12/l

4.4

4.5

5.28

427

4077

(3010813) Leukocytes [#/volume] in Blood

427

4193

1.58

0.89

64.0

18.1

e9/l

6.9

6.6

0.84

427

4075

(3000963) Hemoglobin [Mass/volume] in Blood

427

4194

1.57

0.88

64.4

18.2

g/l

130.1

136.0

12.04

427

4139

(40768441) Liver Pathology biopsy report

2.01

0.87

1.2

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.01

0.87

1.2

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

344

3297

1.20

0.83

6.2

5.3

mmol/mol

39.0

39.1

0.05

330

3092

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

257

0.69

0.79

1.6

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.79

0.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.64

0.79

1.2

1.1

u/ml

0.5

0.3

—

(3015183) Erythrocyte sedimentation rate

0.00

0.78

0.0

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

349

3613

0.84

0.77

4.8

4.2

mmol/l

4.7

4.8

0.60

336

3383

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.77

0.0

1.5

—

7.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

364

3513

1.21

0.77

50.8

12.9

39.4

40.4

2.84

308

2719

(40761535) Cells panel - Urine sediment

255

1.32

0.74

7.1

3.4

—

(4024509)

2.01

0.73

1.4

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

1.42

0.71

1.4

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

335

3469

0.86

0.68

4.6

3.8

mmol/l

1.4

1.3

2.02

322

3221

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

433

1.23

0.66

2.5

2.8

ug/l

0.5

0.7

2.70

261

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

147

1.38

0.63

1.7

2.2

u/l

303.6

4021.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.56

0.62

2.0

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

418

0.80

0.59

4.9

4.2

30.3

32.2

0.43

282

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.63

0.55

1.5

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

241

1.26

0.54

1.1

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

350

3595

0.87

0.53

4.7

4.2

mmol/l

1.5

0.40

333

3351

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.41

0.51

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.61

0.46

13.0

4.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

140

1.30

0.42

2.3

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1.36

0.42

1.3

2.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.40

0.0

1.1

—

7.1

—

(4281824)

1.43

0.39

1.8

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

359

3659

0.90

0.35

5.3

4.6

mmol/l

2.7

2.9

1.42

342

3405

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

686

1.11

0.33

1.6

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

231

0.81

0.33

2.7

1.7

—

(3011288) Drugs identified in Urine by Screen method

129

1.25

0.30

1.4

3.0

—

(3019150) Specific gravity of Urine by Refractometry

787

1.10

0.30

5.8

3.5

kg/l

1.0

—

105

(40768793) Breast Pathology biopsy report

117

0.76

0.27

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

197

1.18

0.26

1.2

1.9

—

(3027008) Opiates [Presence] in Urine

197

1.18

0.26

1.2

1.9

—

(3028300) Cannabinoids [Presence] in Urine

197

1.18

0.26

1.2

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

151

1.20

0.25

1.2

2.1

—

(3049717) Cytology report of Urine Cyto stain

106

1.23

0.23

2.8

2.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1.22

0.22

2.8

2.7

mmol/l

106.0

105.7

—

(3041354) Potassium [Moles/volume] in Venous blood

1.22

0.22

2.8

2.7

mmol/l

4.2

3.9

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.21

0.0

6.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

115

0.78

0.20

1.8

1.4

—

(3000330) Specific gravity of Urine by Test strip

147

1.16

0.18

6.8

3.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

184

0.86

0.17

1.4

1.5

—

(3022621) pH of Urine by Test strip

205

1.13

0.17

3.8

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

593

1.07

0.17

3.2

4.1

16.8

21.0

2.46

255

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.11

0.17

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.11

0.16

1.1

1.3

—

(3027944) Amphetamines [Presence] in Urine

197

1.12

0.15

1.2

1.8

—

(3005033) Fetal Nuchal fold Thickness US

1.11

0.15

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.11

0.15

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.09

0.14

1.3

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

228

1.10

0.13

1.0

—

(3016879) Cocaine [Presence] in Urine

181

1.11

0.12

1.2

2.0

—

(3013512) EKG study

936

0.97

0.09

4.7

3.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

347

3495

0.97

0.08

4.9

4.2

mmol/l

5.9

5.8

0.42

337

3222

(4094501)

1.07

0.07

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

105

0.85

0.06

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

499

0.98

0.02

1.6

1.9

1.6

1.4

0.73

448

(3019225) pH of Specimen

313

0.99

0.00

9.2

4.3

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.95

0.00

1.2

1.4

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

34.3

—

(44806420)

0.00

0.0

2.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.2

—

59.2

—

(4133840)

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.0

2.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.95

0.00

1.2

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.95

0.00

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.95

0.00

1.2

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.0

1.2

—

5.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.97

0.00

1.7

5.0

umol/l

314.6

371.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

1.4

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_IMMUDEFANTIBODYNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_IMMUDEFANTIBODYNAS	3.692 [2.74, 4.98]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.678

During the follow-up period (1.1.1998 — 31.12.2019), 114 out of 759 females with D3_IMMUDEFANTIBODYNAS died.

Males

Parameter	HR [95% CI]	p-value
D3_IMMUDEFANTIBODYNAS	4.194 [2.91, 6.04]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 101 out of 537 males with D3_IMMUDEFANTIBODYNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_IMMUDEFANTIBODYNAS.

N-year risk	Females	Males
1	0.49%	0.783%
5	2.474%	4.738%
10	6.1%	11.305%
15	11.228%	20.533%
20	18.82%	33.16%

Relationships between endpoints

↥

Index endpoint: D3_IMMUDEFANTIBODYNAS – Other and unspecified immunodeficiencies with predominantly antibody defects

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified immunodeficiencies with predominantly antibody defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints